Nitric oxide, the kidney and hypertension

Clin Exp Pharmacol Physiol. 1997 Aug;24(8):600-6. doi: 10.1111/j.1440-1681.1997.tb02099.x.

Abstract

1. According to the renal body fluid feedback mechanism for long-term control, persistent hypertension can only occur as a result of a reduction in renal sodium excretory function or a hypertensive shift in the pressure natriuresis relationship. Although an abnormal relationship between renal perfusion pressure and renal sodium excretion has been identified in every type of hypertension where it has been sought, factors responsible for this effect are still unclear. 2. Nitric oxide (NO) is produced within the kidney and plays an important role in the control of many intrarenal processes that regulate the renal response to changes in perfusion pressure and, thus, help determine systemic vascular volume and blood pressure. Numerous studies have shown that long-term inhibition of NO synthesis results in a chronic hypertensive shift in renal pressure natriuresis. 3. Recent studies have shown that certain animal models of genetic hypertension and forms of human hypertension areas are associated with a decrease in NO synthesis. Reductions in NO synthesis reduce renal sodium excretory function, not only through direct action on the renal vasculature, but through modulation of other vasoconstrictor processes and through direct and indirect alterations in tubular sodium transport. 4. The causes and consequences of the disregulation of NO in hypertension and other renal disease processes remain an important area of investigation.

MeSH terms

  • Animals
  • Dogs
  • Enzyme Inhibitors / pharmacology
  • Glomerular Filtration Rate / drug effects
  • Hypertension / physiopathology*
  • Kidney / drug effects
  • Kidney / physiopathology*
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Natriuresis / drug effects
  • Nitric Oxide / physiology*

Substances

  • Enzyme Inhibitors
  • Nitric Oxide
  • NG-Nitroarginine Methyl Ester